Biogen scraps two late-stage trials for Alzheimer’s treatment EP News Bureau Sep 17, 2019 The decision was based on the results of a review conducted by a data safety monitoring board, which recommended discontinuing the…
DRL in agreement with Eisai Co, Japan Usha Sharma Mar 31, 2016 Acquires rights to Investigational Anticancer Agent E7777 for US, Europe and certain emerging markets from Eisai
